The telehealth flexibilities allowed during the Covid-19 public health emergency greatly expanded access to healthcare services. But after the public health emergency ends, it’s ultimately up to Congress to further extend these flexibilities, said…
Continue Reading
Novo Nordisk is slashing prices of several insulin products by up to 75% amid growing political scrutiny on the prices of these older but still expensive diabetes medicines. The announcement Tuesday comes two weeks…
Continue Reading
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient […]
Continue Reading
What You Should Know:– Sanofi has agreed to acquire Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), for $25.00 per share in cash, representing an equity…
Continue Reading
More than a decade after the Affordable Care Act was signed into law, U.S. healthcare costs continue to spiral at rates unseen in the rest of the developed world.
But while healthcare costs overall are…
We present a robust insulin delivery system that includes automated meal detection and carbohydrate content estimation using machine learning for meal insulin dosing called robust artificial pancreas (RAP). We conducted a randomized, single-center crossover…
Continue Reading
Health apps are not only empowering patients, but also providing clinicians with early access to important insights to support evidence-based care, says Dr Haidar Samiei, a consultant in emergency medicine and a clinical director…
Continue ReadingWhat You Should Know:[embedded content]– Eli Lilly and Company today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less…
Continue Reading
Eli Lilly is cutting insulin prices, and this time it’s for real.
Months after a Twitter account posing as the drugmaker went viral with a tweet stating, “insulin is free now,” the company on Wednesday…
